Jean-Pierre J. Issa, MD of Fox Chase Cancer Center Fels Institute for Cancer Research & Molecular Biology at Temple University gives an overview of presentations at AACR 2017, specifically on immunotherapy. He states that in order to make immunotherapy work better for patients, the idea of combining immunotherapy with epigenetic therapy is a possibility moving forward. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
